Clinical Trials Logo

Clinical Trial Summary

A Multicenter, Randomized, Single-Blind Study with an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02571738
Study type Interventional
Source Osiris Therapeutics
Contact
Status Terminated
Phase Phase 3
Start date October 2015
Completion date June 2017

See also
  Status Clinical Trial Phase
Recruiting NCT04457752 - Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®) Phase 4
Completed NCT00632008 - Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers Phase 3
Recruiting NCT00366132 - Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers Phase 2
Terminated NCT05276401 - Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer Phase 2
Completed NCT03282981 - Beta Adrenergic Antagonist for the Healing of Chronic DFU Phase 3
Completed NCT02098447 - Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds N/A
Withdrawn NCT00954343 - Shockwave Treatment of Diabetic Foot Ulcer: Step I N/A
Recruiting NCT04962139 - Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers Phase 3